ATE336579T1 - Isolierte mhc-klasse ii-bindende peptide, und deren verwendung - Google Patents

Isolierte mhc-klasse ii-bindende peptide, und deren verwendung

Info

Publication number
ATE336579T1
ATE336579T1 AT00965439T AT00965439T ATE336579T1 AT E336579 T1 ATE336579 T1 AT E336579T1 AT 00965439 T AT00965439 T AT 00965439T AT 00965439 T AT00965439 T AT 00965439T AT E336579 T1 ATE336579 T1 AT E336579T1
Authority
AT
Austria
Prior art keywords
mhc class
binding peptides
isolated mhc
peptides
molecules
Prior art date
Application number
AT00965439T
Other languages
English (en)
Inventor
Ozlem Tureci
Ugur Sahin
Michael Pfreundschuh
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE336579T1 publication Critical patent/ATE336579T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00965439T 1999-09-29 2000-09-26 Isolierte mhc-klasse ii-bindende peptide, und deren verwendung ATE336579T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/408,036 US6800730B1 (en) 1998-10-02 1999-09-29 Isolated peptides which bind to MHC class II molecules, and uses thereof

Publications (1)

Publication Number Publication Date
ATE336579T1 true ATE336579T1 (de) 2006-09-15

Family

ID=23614589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965439T ATE336579T1 (de) 1999-09-29 2000-09-26 Isolierte mhc-klasse ii-bindende peptide, und deren verwendung

Country Status (6)

Country Link
US (2) US6800730B1 (de)
EP (1) EP1220908B1 (de)
AT (1) ATE336579T1 (de)
AU (1) AU7615900A (de)
DE (1) DE60030141T2 (de)
WO (1) WO2001023560A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7619057B2 (en) 2000-01-28 2009-11-17 The United States Of America As Represented By The Secretary, Department Of Health And Human Services MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
US8637305B2 (en) * 2001-11-07 2014-01-28 Mannkind Corporation Expression vectors encoding epitopes of target-associated antigens and methods for their design
US20080139464A1 (en) * 2003-05-30 2008-06-12 Ludwig Institute Of Cancer Research Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof
EP1644501B1 (de) 2003-07-22 2011-01-19 Ludwig Institute For Cancer Research Von hla-klasse-ii-molekülen präsentierte ssx-2-peptide
US7632506B2 (en) * 2004-09-09 2009-12-15 Ludwig Institute For Cancer Research Identification of new NY-ESO-1 epitopes recognized by CD4+ T-cells
US20070232558A1 (en) * 2006-03-31 2007-10-04 Mcneel Douglas G Methods and compositions for treating prostate cancer using dna vaccines directed to cancer testis antigen
US7910565B2 (en) 2006-09-01 2011-03-22 Wisconsin Alumni Research Foundation Prostate cancer vaccine
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
WO2008121836A1 (en) * 2007-03-30 2008-10-09 Brigham And Women's Hospital, Inc. Compounds and methods for enhancing mhc class ii therapies
CN102575284A (zh) 2009-03-17 2012-07-11 MDx健康公司 改进的基因表达检测
BR122020026648B1 (pt) 2010-09-20 2021-12-07 Biontech Cell & Gene Therapies Gmbh Receptor de células t com especificidade para ny-eso-1, composição farmacêutica compreendendo o mesmo e uso do mesmo

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723832B1 (en) * 1996-10-03 2004-04-20 Ludwig Institute For Cancer Research Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
DE69334076D1 (de) * 1992-08-07 2006-11-30 Pharmexa Inc Hla bindepeptide und ihre verwendungen
DE69435171D1 (de) * 1993-09-14 2009-01-08 Pharmexa Inc Pan dr-bindeproteinen zur erhöhung der immunantwort
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
GB9414580D0 (en) * 1994-07-19 1994-09-07 Cancer Res Campaign Tech Materials and methods relating to the diagnosis of synovial sarcomas
US6251603B1 (en) * 1996-10-03 2001-06-26 Ludwig Institute For Cancer Research Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample
US6413517B1 (en) * 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
US6287756B1 (en) * 1997-05-05 2001-09-11 Ludwig Institute For Cancer Research Methods for determining presence of cancer in a sample by determining expression of an SSX gene
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
ES2281935T3 (es) * 1997-10-08 2007-10-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Antigeno cancerigeno humano ny eso-1/ca6 y gen que codifica para el mismo.
JP2002506633A (ja) * 1998-03-20 2002-03-05 ジェンザイム・コーポレーション Ｔ細胞応答を誘発するための遺伝子に基づくワクチンの組成物および使用法

Also Published As

Publication number Publication date
EP1220908A2 (de) 2002-07-10
WO2001023560A2 (en) 2001-04-05
US20040214284A1 (en) 2004-10-28
US6800730B1 (en) 2004-10-05
US7385044B2 (en) 2008-06-10
DE60030141T2 (de) 2007-08-09
WO2001023560A3 (en) 2001-11-29
AU7615900A (en) 2001-04-30
EP1220908B1 (de) 2006-08-16
DE60030141D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
EA200501206A1 (ru) Производные от сурвивина пептиды и их применение
BR9911389A (pt) Composição de peptìdio como imunógeno para o tratamento de alergia
ATE336579T1 (de) Isolierte mhc-klasse ii-bindende peptide, und deren verwendung
DK0810870T3 (da) Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
CY1109179T1 (el) Ενα εκλεκτικο αντισωμα για υποδοχεα συνδετη που επαγει αποπτωση σχετιζομενη με παραγοντα νεκρωσης ογκων και χρησεις του
EP1071443A4 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE405582T1 (de) P53 bindende t-zellrezeptormoleküle und deren verwendungen
MXPA04005992A (es) Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa.
NZ509417A (en) Novel peptides for use in immunotherapy of autoimmune diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220908

Country of ref document: EP